Catapulting clopidogrel pharmacogenomics forward

Nature Medicine

Volumn 17, Issue 1, 2011, Pages 40-41

  Topol, Eric J ^a,b   Schork, Nicholas J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b SCRIPPS CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; CLOPIDOGREL; CYTOCHROME P450 2C19;

ARTICLE; DNA POLYMORPHISM; DRUG EFFICACY; DRUG METABOLISM; ENZYME ACTIVATION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; PHARMACOGENOMICS; PRIORITY JOURNAL; STENT THROMBOSIS;

AMINO ACID SUBSTITUTION; ARYLDIALKYLPHOSPHATASE; ASPIRIN; BLOOD PLATELETS; DRUG THERAPY, COMBINATION; HUMANS; PLATELET AGGREGATION INHIBITORS; PURINERGIC P2Y RECEPTOR ANTAGONISTS; STENTS; THROMBOSIS; TICLOPIDINE;

EID: 78651239462     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm0111-40     Document Type: Article

References (13)

1. Topol, E.J. Textbook of Interventional Cardiology. 5th edn. Ch. 66, 1221-1240 (Elsevier, Philadelphia, 2008).
2. Winslow, R. Plavix rival gains from studies. Wall Street Journal (30 August 2010).
3. Serebruany, V.L. et al. J. Am. Coll. Cardiol. 45, 246-251 (2005).
4. Mauri, L. et al. N. Engl. J. Med. 356, 1020-1029 (2007).
5. Bouman, H.J. et al. Nat. Med. 17, 110-116 (2011).
6. Hulot, J.S. et al. Blood 108, 2244-2247 (2006).
7. Simon, T. et al. N. Engl. J. Med. 360, 363-375 (2009).
8. Collet, J.P. et al. Lancet 373, 309-317 (2009).
9. Mega, J.L. et al. N. Engl. J. Med. 360, 354-362 (2009).
10. Hulot, J.S. et al. J. Am. Coll. Cardiol. 56, 134-143 (2010).
11. Mega, J.L. et al. J. Am. Med. Assoc. 304, 1821-1830 (2010).
12. Shuldiner, A.R. et al. J. Am. Med. Assoc. 302, 849-857 (2009).
13. Damani, S.B. & Topol, E.J. J. Am. Coll. Cardiol. 56, 109-111 (2010).